Photo by nci from unsplash
Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is a… Click to show full abstract
Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is a lack of evidence whether patients with myocarditis and impaired LVEF may benefit from treatment with a WCD.
Keywords:
friend foe;
wearable cardioverter;
cardioverter defibrillator;
defibrillator friend
Journal Title: ESC Heart Failure
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: ESC Heart Failure
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!